CAD General

(P047) A PROSPECTIVE STUDY USING WHOLE EXOME SEQUENCING (WES) IN A CANADIAN POPULATION WITH HYPERTROPHIC CARDIOMYOPATHY.

(P048) A SIMPLE DOSING RULE TO IMPROVE EFFICACY AND SAFETY OF TICAGRELOR

(P050) CAN IMPROVING THE EFFECTIVENESS OF INTERHOSPITAL TRANSFER WITHIN BRITISH COLUMBIA AND THE YUKON TERRITORY FOR CARDIAC PATIENTS HELP NARROW HEALTH DISPARITIES?

(P051) CHARACTERIZATION OF PATIENTS SUB-OPTIMALLY TREATED FOR DYSLIPIDEMIA MANAGEMENT IN SECONDARY PREVENTION FOLLOWING THE PUBLICATION OF THE 2021 CCS DYSLIPIDEMIA GUIDELINES

(P054) EVALUATING THE UTILITY AND SAFETY OF A RAPID ACCESS CHEST PAIN CLINIC AT A QUATERNARY REFERRAL CENTRE

(P055) INTEGRATING THE 2020 CANADIAN ADULT OBESITY CLINICAL PRACTICE GUIDELINES INTO A CARDIOVASCULAR REHABILITATION SETTING

(P056) OPTIMIZING SECONDARY PREVENTION USING A NOVEL MULTIDISCIPLINARY RISK REDUCTION CLINIC: INSIGHTS FROM A METROPOLITAN COMMUNITY CARDIOLOGY CLINIC

(P057) SAFETY AND EFFICACY OF INCLISIRAN IN BOTH PRIMARY AND SECONDARY PREVENTION IN A CONTEMPORARY CANADIAN POPULATION

(P058) SELECTIVE BETA BLOCKADE FOR THE TREATMENT OF CORONARY VASOSPASM -ASSOCIATED POLYMORPHIC VENTRICULAR TACHYCARDIA

(P059) SOCIAL DETERMINANTS OF HEALTH AND ADVERSE OUTCOMES IN ARTIAL FIBRILLATION: A UK BIOBANK STUDY

(P060) THE EFFECTS OF AGE AND SEX ON CALCIFICATION AND LUMINAL SURFACE COMPLEXITY IN CADAVERIC LEFT ANTERIOR DESCENDING ARTERIES

(P061) THE RISK OF QTC PROLONGATION IN PATIENTS USING CYCLIN-DEPENDENT KINASE 4/6 IN ADVANCED BREAST CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS

(P063) UNVEILING THE LONGITUDINAL JOURNEY: THREE-YEAR FOLLOW-UP OF WOMEN WITH INOCA AND MINOCA IN A SPECIALIZED HEART CLINIC